Our rescue experiments demonstrated for the first time that MeCP2 promoted breast cancer cell growth and induced apoptosis through suppressing RPL11 and RPL5 transcription by binding to the methylated CpG islands of their promoter regions. Here, RPL5 is linked to breast carcinoma.